HT
Helen Torley (PRESIDENT AND CEO) filed 11 Form 4 reports in the trailing twelve months (0 purchases, 11 sales), most often in Halozyme Therapeutics, Inc. (HALO). The largest single filing was $6.6M of HALO (59,600 sh across 10 lots, as filed), executed Oct 6. Data as of Nov 8 2026.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
11
0 buys · 11 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$37.3M
shares × price, as filed
Last traded
Oct 8
Filed Oct 8
Median ADV $214.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $60.3M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
11 filings
Sector per market data · by filing · past 12 months
Most traded names
HALORecent filings
HALOSALE
Halozyme Therapeutics, Inc.
View filing →
$6.6M59,600 sh across 10 lots
Exec Oct 6
Filed Oct 8 · 7:56 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $6.4M
59,900 sh across 6 lots
Exec Sep 9
Filed Sep 11 · 8:35 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $6.1M
58,600 sh across 9 lots
Exec Aug 17
Filed Aug 19 · 8:01 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $3.3M
49,600 sh across 8 lots
Exec Jun 1
Filed Jun 3 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $3.3M
47,902 sh across 9 lots
Exec May 11
Filed May 13 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $635K
10,000 sh across 2 lots
Exec Apr 6
Filed Apr 7 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $2.5M
39,000 sh across 3 lots
Exec Apr 1
Filed Apr 2 · 5:30 PM ET HALOSALE Halozyme Therapeutics, Inc. View filing → $3.4M
49,422 sh across 6 lots
Exec Mar 2
Filed Mar 4 · 5:30 PM ET More filings →